NCT00476359View on ClinicalTrials.gov

A PK and Salvage Study for Children With HIV-infection

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
HIV Infections
Interventions
DRUG

Lopinavir/r plus saquinavir

lopinavir/ritonavir 230/57.5 mg/m2 orally twice daily and saquinavir 50 mg/kg orally twice daily

Trial Locations (3)

10330

Chulalongkorn University Hospital, Department of Pediatrics, Bangkok

The HIV Netherlands Australia Thailand Research Collaboration, Bangkok

40002

Khon Kaen University, Khon Kaen

All Listed Sponsors
collaborator

Roche for trial and Saquinavir,and Abbott for Kaletra

UNKNOWN

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER

NCT00476359 - A PK and Salvage Study for Children With HIV-infection | Biotech Hunter | Biotech Hunter